Richard Myers, PhD, is a member of Bay City Capital’s Scientific Advisory Board. Dr. Myers is a director and investigator of the HudsonAlpha Institute for Biotechnology. He began his first faculty position at theUniversity of California at San Francisco in 1986 and moved his laboratory to Stanford University’s Department of Genetics in 1993, where he was named professor and later chair. Dr. Myers’s research program is focused on human genetics and genomics. Work in his laboratory has led to the identification of genes involved in several inherited diseases, and his genome center contributed more than 10 percent of the data in the public Human Genome Project’s efforts to sequence the human genome. His lab continues to use genomics tools and genetics to understand how genes interacting with the environment contribute to human diseases and other traits. Dr. Myers received his B.S. in biochemistry from the University of Alabama inTuscaloosa in 1977, his Ph.D. in biochemistry from the University of California at Berkeley in 1982, and his postdoctoral training at Harvard University.